Eicosanoids in skin inflammation

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 1, 2013, Pages 131-138

  Nicolaou, Anna ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Eicosanoids; Inflammation; Polyunsaturated fatty acids; Skin

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; ANTIOXIDANT; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CORIOLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; DIACYLGLYCEROL; DIHOMO GAMMA LINOLENIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LIPOXYGENASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPASE A2; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROSTAGLANDIN E3; PROSTAGLANDIN F2 ALPHA; THROMBOXANE B2;

ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; DERMATITIS; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SYNTHESIS; EPIDERMIS; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; HUMAN; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; PSORIASIS; SKIN FIBROBLAST; SUNBURN;

ANIMALS; DERMATITIS; DERMATITIS, ATOPIC; DIETARY SUPPLEMENTS; EICOSANOIDS; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; OXIDATIVE STRESS; PSORIASIS; SKIN; SUNBURN;

EID: 84872021435     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2012.03.009     Document Type: Article

References (139)

1. Nicolaou A., Pilkington S.M., Rhodes L.E. Ultraviolet-radiation induced skin inflammation: dissecting the role of bioactive lipids. Chem. Phys. Lipids 2011, 164:535-543.
2. Fogh K., Kragballe K. Eicosanoids in inflammatory skin diseases. Prostaglandins Other Lipid Mediat. 2000, 63:43-54.
3. Ikai K. Psoriasis and the arachidonic acid cascade. J. Dermatol. Sci. 1999, 21:135-146.
4. Serhan C.N., Yacoubian S., Yang R. Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 2008, 3:279-312.
5. Massey K.A., Nicolaou A. Lipidomics of polyunsaturated-fatty-acid-derived oxygenated metabolites. Biochem. Soc. Trans. 2011, 39:1240-1246.
6. Proksch E., Brandner J.M., Jensen J.M. The skin: an indispensable barrier. Exp. Dermatol. 2008, 17:1063-1072.
7. Burr G.O., Burr M.M. A new deficiency disease produced by the rigid exclusion of fat from the diet. J. Biol. Chem. 1929, 82:345-367.
8. Hansen H.S., Jensen B. Essential function of linoleic acid esterified in acylglucosylceramide and acylceramide in maintaining the epidermal water permeability barrier. Evidence from feeding studies with oleate, linoleate, arachidonate, columbinate and alpha-linolenate. Biochim. Biophys. Acta. 1985, 834:357-363.
9. McCusker M.M., Grant-Kels J.M. Healing fats of the skin: the structural and immunologic roles of the omega-6 and omega-3 fatty acids. Clin. Dermatol. 2010, 28:440-451.
10. Zuo Y., Zhuang D.Z., Han R., Isaac G., Tobin J.J., McKee M., Welti R., Brissette J.L., Fitzgerald M.L., Freeman M.W. ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic esters. J. Biol. Chem. 2008, 283:36624-36635.
11. Chapkin R.S., Ziboh V.A. Inability of skin enzyme preparations to biosynthesize arachidonic acid from linoleic acid. Biochem. Biophys. Res. Commun. 1984, 124:784-792.
12. Ziboh V.A., Chapkin R.S. Metabolism and function of skin lipids. Prog. Lipid. Res. 1988, 27:81-105.
13. Ziboh V.A. Prostaglandins, leukotrienes, and hydroxy fatty acids in epidermis. Semin. Dermatol. 1992, 11:114-120.
14. Pilkington S.M., Watson R.E., Nicolaou A., Rhodes L.E. Omega-3 polyunsaturated fatty acids: photoprotective macronutrients. Exp. Dermatol. 2011, 20:537-543.
15. Dennis E.A., Cao J., Hsu Y.H., Magrioti V., Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 2011, 111:6130-6185.
16. Chen X., Gresham A., Morrison A., Pentland A.P. Oxidative stress mediates synthesis of cytosolic phospholipase A2 after UVB injury. Biochim. Biophys. Acta. 1996, 1299:23-33.
17. Andersen S., Sjursen W., Laegreid A., Volden G., Johansen B. Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue. Inflammation 1994, 18:1-12.
18. Sjursen W., Brekke O.L., Johansen B. Secretory and cytosolic phospholipase A(2)regulate the long-term cytokine-induced eicosanoid production in human keratinocytes. Cytokine 2000, 12:1189-1194.
19. Bergers M., van de Kerkhof P.C., Happle R., Mier P.D. Membrane-bound phospholipase C activity in normal and psoriatic epidermis. Acta Derm. Venereol. 1990, 70:57-59.
20. Oka M., Edamatsu H., Kunisada M., Hu L., Takenaka N., Dien S., Sakaguchi M., Kitazawa R., Norose K., Kataoka T., Nishigori C. Enhancement of ultraviolet B-induced skin tumor development in phospholipase Cepsilon-knockout mice is associated with decreased cell death. Carcinogenesis 2010, 31:1897-1902.
21. Sugimoto M., Arai I., Futaki N., Hashimoto Y., Honma Y., Nakaike S. Role of COX-1 and COX-2 on skin PGs biosynthesis by mechanical scratching in mice. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75:1-8.
22. Rhodes L.E., Gledhill K., Masoodi M., Haylett A.K., Brownrigg M., Thody A.J., Tobin D.J., Nicolaou A. The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J. 2009, 23:3947-3956.
23. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 2002, 23:144-150.
24. Black A.T., Gray J.P., Shakarjian M.P., Mishin V., Laskin D.L., Heck D.E., Laskin J.D. UVB light upregulates prostaglandin synthases and prostaglandin receptors in mouse keratinocytes. Toxicol. Appl. Pharmacol. 2008, 232:14-24.
25. Konger R.L., Malaviya R., Pentland A.P. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. Biochim. Biophys. Acta 1998, 1401:221-234.
26. Honda T., Matsuoka T., Ueta M., Kabashima K., Miyachi Y., Narumiya S. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity. J. Allergy Clin. Immunol. 2009, 124:809-818. e802.
27. Scott G., Leopardi S., Printup S., Malhi N., Seiberg M., Lapoint R. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity. J. Invest. Dermatol. 2004, 122:1214-1224.
28. Kudo I., Murakami M. Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J. Biochem. Mol. Biol. 2005, 38:633-638.
29. Ueno N., Takegoshi Y., Kamei D., Kudo I., Murakami M. Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem. Biophys. Res. Commun. 2005, 338:70-76.
30. Honma Y., Arai I., Hashimoto Y., Futaki N., Sugimoto M., Tanaka M., Nakaike S. Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice. Eur. J. Pharmacol. 2005, 518:56-62.
31. Pentland A.P., Needleman P. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J. Clin. Invest. 1986, 77:246-251.
32. Leong J., Hughes-Fulford M., Rakhlin N., Habib A., Maclouf J., Goldyne M.E. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp. Cell Res. 1996, 224:79-87.
33. Sato T., Kirimura Y., Mori Y. The co-culture of dermal fibroblasts with human epidermal keratinocytes induces increased prostaglandin E2 production and cyclooxygenase 2 activity in fibroblasts. J. Invest. Dermatol. 1997, 109:334-339.
34. Parekh A., Sandulache V.C., Singh T., Cetin S., Sacks M.S., Dohar J.E., Hebda P.A. Prostaglandin E2 differentially regulates contraction and structural reorganization of anchored collagen gels by human adult and fetal dermal fibroblasts. Wound Repair Regen. 2009, 17:88-98.
35. Ruzicka T. The role of the epidermal 12-hydroxyeicosatetraenoic acid receptor in the skin. Eicosanoids 1992, 5(Suppl):S63-65.
36. Gledhill K., Rhodes L.E., Brownrigg M., Haylett A.K., Masoodi M., Thody A.J., Nicolaou A., Tobin D.J. Prostaglandin-E2 is produced by adult human epidermal melanocytes in response to UVB in a melanogenesis-independent manner. Pigment Cell Melanoma Res. 2010, 23:394-403.
37. Masoodi M., Nicolaou A., Gledhill K., Rhodes L.E., Tobin D.J., Thody A.J. Prostaglandin D production in FM55 melanoma cells is regulated by alpha-melanocyte-stimulating hormone and is not related to melanin production. Exp. Dermatol. 2010, 19:751-753.
38. Scott G., Fricke A., Fender A., McClelland L., Jacobs S. Prostaglandin E2 regulates melanocyte dendrite formation through activation of PKCzeta. Exp. Cell Res. 2007, 313:3840-3850.
39. Ikai K., Imamura S. Prostaglandin D2 in the skin. Int. J. Dermatol. 1988, 27:141-149.
40. Satoh T., Moroi R., Aritake K., Urade Y., Kanai Y., Sumi K., Yokozeki H., Hirai H., Nagata K., Hara T., Utsuyama M., Hirokawa K., Sugamura K., Nishioka K., Nakamura M. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J. Immunol. 2006, 177:2621-2629.
41. Kanda N., Ishikawa T., Watanabe S. Prostaglandin D2 induces the production of human beta-defensin-3 in human keratinocytes. Biochem. Pharmacol. 2010, 79:982-989.
42. Shimura C., Satoh T., Igawa K., Aritake K., Urade Y., Nakamura M., Yokozeki H. Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin. Am. J. Pathol. 2010, 176:227-237.
43. Takeda K., Yokoyama S., Aburatani H., Masuda T., Han F., Yoshizawa M., Yamaki N., Yamamoto H., Eguchi N., Urade Y., Shibahara S. Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF. Biochem. Biophys. Res. Commun. 2006, 339:1098-1106.
44. Straus D.S., Glass C.K. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med. Res. Rev. 2001, 21:185-210.
45. Ikai K., Yamamoto M., Matsuyoshi N., Fukushima M. Effect of cytotoxic prostaglandin, delta 12-prostaglandin J2 on E-cadherin expression in transformed epidermal cells in culture. Prostaglandins Leukot. Essent. Fatty Acids 1995, 52:303-307.
46. Watanabe K. Recent reports about enzymes related to the synthesis of prostaglandin (PG) F(2) (PGF(2alpha) and 9alpha, 11beta-PGF(2)). J Biochem 2011, 150:593-596.
47. Ziboh V.A., Lord J.T., Penneys N.S. Alterations of prostaglandin E2-9-ketoreductase activity in proliferating skin. J. Lipid Res. 1977, 18:37-43.
48. Colombe L., Vindrios A., Michelet J.F., Bernard B.A. Prostaglandin metabolism in human hair follicle. Exp. Dermatol. 2007, 16:762-769.
49. Scott G., Jacobs S., Leopardi S., Anthony F.A., Learn D., Malaviya R., Pentland A. Effects of PGF2alpha on human melanocytes and regulation of the FP receptor by ultraviolet radiation. Exp. Cell Res. 2005, 304:407-416.
50. Weber T.J., Markillie L.M., Chrisler W.B., Vielhauer G.A., Regan J.W. Modulation of JB6 mouse epidermal cell transformation response by the prostaglandin F2alpha receptor. Mol. Carcinog. 2002, 35:163-172.
51. Muller K., Krieg P., Marks F., Furstenberger G. Expression of PGF(2alpha) receptor mRNA in normal, hyperplastic and neoplastic skin. Carcinogenesis 2000, 21:1063-1066.
52. Andoh T., Nishikawa Y., Yamaguchi-Miyamoto T., Nojima H., Narumiya S., Kuraishi Y. Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice. J. Invest. Dermatol. 2007, 127:2042-2047.
53. Nakajima S., Honda T., Sakata D., Egawa G., Tanizaki H., Otsuka A., Moniaga C.S., Watanabe T., Miyachi Y., Narumiya S., Kabashima K. Prostaglandin I2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity. J Immunol 2010, 184:5595-5603.
54. Bryniarski K., Biedron R., Jakubowski A., Chlopicki S., Marcinkiewicz J. Anti-inflammatory effect of 1-methylnicotinamide in contact hypersensitivity to oxazolone in mice; involvement of prostacyclin. Eur. J. Pharmacol. 2008, 578:332-338.
55. Tai H.H., Ensor C.M., Tong M., Zhou H., Yan F. Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediat. 2002, 68-69:483-493.
56. Judson B.L., Miyaki A., Kekatpure V.D., Du B., Gilleaudeau P., Sullivan-Whalen M., Mohebati A., Nair S., Boyle J.O., Granstein R.D., Subbaramaiah K., Krueger J.G., Dannenberg A.J. UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression. Cancer Prev. Res. (Philadelphia) 2010, 3:1104-1111.
57. Fincham N., Camp R. Novel prostaglandin dehydrogenase in rat skin. Biochem. J. 1983, 212:129-134.
58. Brash A.R. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 1999, 274:23679-23682.
59. Kuhn H., O'Donnell V.B. Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid. Res. 2006, 45:334-356.
60. Miller C.C., Tang W., Ziboh V.A., Fletcher M.P. Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites. J. Invest. Dermatol. 1991, 96:98-103.
61. Lu Y., Tian H., Hong S. Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing. J. Lipid. Res. 2010, 51:923-932.
62. Nicolaou A., Masoodi M., Gledhill K., Haylett A.K., Thody A.J., Tobin D.J., Rhodes L.E. The eicosanoid response to high dose UVR exposure of individuals prone and resistant to sunburn. Photochem. Photobiol. Sci. 2012, 11:371-380.
63. Mayer B., Rauter L., Zenzmaier E., Gleispach H., Esterbauer H. Characterization of lipoxygenase metabolites of arachidonic acid in cultured human skin fibroblasts. Biochim. Biophys. Acta 1984, 795:151-161.
64. Grant G.E., Rokach J., Powell W.S. 5-Oxo-ETE and the OXE receptor. Prostaglandins Other Lipid Mediat. 2009, 89:98-104.
65. Serhan C.N., Jain A., Marleau S., Clish C., Kantarci A., Behbehani B., Colgan S.P., Stahl G.L., Merched A., Petasis N.A., Chan L., Van Dyke T.E. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol. 2003, 171:6856-6865.
66. Ziboh V.A., Casebolt T.L., Marcelo C.L., Voorhees J.J. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin. J. Invest. Dermatol. 1984, 83:426-430.
67. Grabbe J., Czarnetzki B.M., Mardin M. Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes. Arch. Dermatol. Res. 1984, 276:128-130.
68. Doepping S., Funk C.D., Habenicht A.J., Spanbroek R. Selective 5-lipoxygenase expression in Langerhans cells and impaired dendritic cell migration in 5-LO-deficient mice reveal leukotriene action in skin. J. Invest. Dermatol. 2007, 127:1692-1700.
69. Spanbroek R., Stark H.J., Janssen-Timmen U., Kraft S., Hildner M., Andl T., Bosch F.X., Fusenig N.E., Bieber T., Radmark O., Samuelsson B., Habenicht A.J. 5-Lipoxygenase expression in Langerhans cells of normal human epidermis. Proc Natl. Acad. Sci. USA 1998, 95:663-668.
70. Janssen-Timmen U., Vickers P.J., Wittig U., Lehmann W.D., Stark H.J., Fusenig N.E., Rosenbach T., Radmark O., Samuelsson B., Habenicht A.J. Expression of 5-lipoxygenase in differentiating human skin keratinocytes. Proc. Natl. Acad. Sci. USA 1995, 92:6966-6970.
71. Boyce J.A. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol. Rev. 2007, 217:168-185.
72. Bray M.A. Leukotriene B4: an inflammatory mediator with vascular actions in vivo. Agents Actions Suppl. 1982, 11:51-61.
73. Goetzl E.J., Goldman D.W., Naccache P.H., Sha'afi R.I., Pickett W.C. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid. Adv. Prostaglandin Thromboxane Leukot. Res. 1982, 9:273-282.
74. Church M.K., Griffiths T.J., Jeffery S., Ravell L.C., Cowburn A.S., Sampson A.P., Clough G.F. Are cysteinyl leukotrienes involved in allergic responses in human skin?. Clin. Exp. Allergy 2002, 32:1013-1019.
75. Boeglin W.E., Kim R.B., Brash A.R. A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression. Proc. Natl. Acad. Sci. USA 1998, 95:6744-6749.
76. Zheng Y., Yin H., Boeglin W.E., Elias P.M., Crumrine D., Beier D.R., Brash A.R. Lipoxygenases mediate the effect of essential fatty acid in skin barrier formation: a proposed role in releasing omega-hydroxyceramide for construction of the corneocyte lipid envelope. J. Biol. Chem. 2011, 286:24046-24056.
77. Epp N., Furstenberger G., Muller K., de Juanes S., Leitges M., Hausser I., Thieme F., Liebisch G., Schmitz G., Krieg P. 12R-lipoxygenase deficiency disrupts epidermal barrier function. J. Cell Biol. 2007, 177:173-182.
78. Jisaka M., Kim R.B., Boeglin W.E., Nanney L.B., Brash A.R. Molecular cloning and functional expression of a phorbol ester-inducible 8S-lipoxygenase from mouse skin. J. Biol. Chem. 1997, 272:24410-24416.
79. Krieg P., Kinzig A., Heidt M., Marks F., Furstenberger G. cDNA cloning of a 8-lipoxygenase and a novel epidermis-type lipoxygenase from phorbol ester-treated mouse skin. Biochim. Biophys. Acta 1998, 1391:7-12.
80. Kragballe K., Pinnamaneni G., Desjarlais L., Duell E.A., Voorhees J.J. Dermis-derived 15-hydroxy-eicosatetraenoic acid inhibits epidermal 12-lipoxygenase activity. J. Invest. Dermatol. 1986, 87:494-498.
81. Yoo H., Jeon B., Jeon M.S., Lee H., Kim T.Y. Reciprocal regulation of 12- and 15-lipoxygenases by UV-irradiation in human keratinocytes. FEBS Lett. 2008, 582:3249-3253.
82. Schweiger D., Furstenberger G., Krieg P. Inducible expression of 15-lipoxygenase-2 and 8-lipoxygenase inhibits cell growth via common signaling pathways. J. Lipid. Res. 2007, 48:553-564.
83. Ziboh V.A., Miller C.C., Cho Y. Significance of lipoxygenase-derived monohydroxy fatty acids in cutaneous biology. Prostaglandins Other Lipid Mediat. 2000, 63:3-13.
84. Xi S., Pham H., Ziboh V.A. Suppression of proto-oncogene (AP-1) in a model of skin epidermal hyperproliferation is reversed by topical application of 13-hydroxyoctadecadienoic acid and 15-hydroxyeicosatrienoic acid. Prostaglandins Leukot. Essent. Fatty Acids 2000, 62:13-19.
85. Baron J.M., Wiederholt T., Heise R., Merk H.F., Bickers D.R. Expression and function of cytochrome p450-dependent enzymes in human skin cells. Curr. Med. Chem. 2008, 15:2258-2264.
86. Keeney D.S., Skinner C., Wei S., Friedberg T., Waterman M.R. A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unusual selectivity, producing a single major epoxyeicosatrienoic acid. J. Biol. Chem. 1998, 273:9279-9284.
87. Keeney D.S., Skinner C., Travers J.B., Capdevila J.H., Nanney L.B., King L.E., Waterman M.R. Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity. J. Biol. Chem. 1998, 273:32071-32079.
88. Du L., Yermalitsky V., Ladd P.A., Capdevila J.H., Mernaugh R., Keeney D.S. Evidence that cytochrome P450 CYP2B19 is the major source of epoxyeicosatrienoic acids in mouse skin. Arch. Biochem. Biophys. 2005, 435:125-133.
89. Ladd P.A., Du L., Capdevila J.H., Mernaugh R., Keeney D.S. Epoxyeicosatrienoic acids activate transglutaminases in situ and induce cornification of epidermal keratinocytes. J. Biol. Chem. 2003, 278:35184-35192.
90. Milne G.L., Yin H., Morrow J.D. Human biochemistry of the isoprostane pathway. J. Biol. Chem. 2008, 283:15533-15537.
91. Baer A.N., Costello P.B., Green F.A. Stereospecificity of the products of the fatty acid oxygenases derived from psoriatic scales. J. Lipid Res. 1991, 32:341-347.
92. Grundmann J.U., Wiswedel I., Hirsch D., Gollnick H.P. Detection of monohydroxyeicosatetraenoic acids and F2-isoprostanes in microdialysis samples of human UV-irradiated skin by gas chromatography-mass spectrometry. Skin Pharmacol. Physiol. 2004, 17:37-41.
93. Lowes M.A., Bowcock A.M., Krueger J.G. Pathogenesis and therapy of psoriasis. Nature 2007, 445:866-873.
94. Pietrzak A., Michalak-Stoma A., Chodorowska G., Szepietowski J.C. Lipid disturbances in psoriasis: an update. Mediators Inflamm 2010.
95. Fisher G.J., Talwar H.S., Tavakkol A., Esmann J., Baldassare J.J., Elder J.T., Griffiths C.E., Baadsgaard O., Cooper K.D., Voorhees J.J. Phosphoinositide-mediated signal transduction in normal and psoriatic epidermis. J. Invest. Dermatol. 1990, 95:15S-17S.
96. Grabbe J., Czarnetzki B.M., Rosenbach T., Mardin M. Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J. Invest. Dermatol. 1984, 82:477-479.
97. Kragballe K., Duell E.A., Voorhees J.J. Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis. Arch. Dermatol. 1986, 122:877-880.
98. Baer A.N., Costello P.B., Green F.A. Free and esterified 13(R,S)-hydroxyoctadecadienoic acids: principal oxygenase products in psoriatic skin scales. J. Lipid. Res. 1990, 31:125-130.
99. Zhou Q., Mrowietz U., Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radic. Biol. Med. 2009, 47:891-905.
100. Stark K., Torma H., Oliw E.H. Co-localization of COX-2, CYP4F8, and mPGES-1 in epidermis with prominent expression of CYP4F8 mRNA in psoriatic lesions. Prostaglandins Other Lipid Mediat. 2006, 79:114-125.
101. Carlson R.P., O'Neill-Davis L., Calhoun W., Datko L., Musser J.H., Kreft A.F., Chang J.Y. Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation. Agents Actions 1989, 26:319-328.
102. Ford-Hutchinson A.W. 5-Lipoxygenase activation in psoriasis: a dead issue?. Skin Pharmacol. 1993, 6:292-297.
103. Fogh K., Sogaard H., Herlin T., Kragballe K. Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxyeicosatetraenoic acid (15-HETE). J. Am. Acad. Dermatol. 1988, 18:279-285.
104. Fogh K., Hansen E.S., Herlin T., Knudsen V., Henriksen T.B., Ewald H., Bunger C., Kragballe K. 15-Hydroxy-eicosatetraenoic acid (15-HETE) inhibits carrageenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4). Prostaglandins 1989, 37:213-228.
105. Zulfakar M.H., Edwards M., Heard C.M. Is there a role for topically delivered eicosapentaenoic acid in the treatment of psoriasis?. Eur. J. Dermatol. 2007, 17:284-291.
106. Mayser P., Grimm H., Grimminger F. n-3 fatty acids in psoriasis. Br. J. Nutr. 2002, 87(Suppl. 1):S77-82.
107. Ricketts J.R., Rothe M.J., Grant-Kels J.M. Nutrition and psoriasis. Clin Dermatol 2010, 28:615-626.
108. Miller C.C., McCreedy C.A., Jones A.D., Ziboh V.A. Oxidative metabolism of dihomogammalinolenic acid by guinea pig epidermis: evidence of generation of anti-inflammatory products. Prostaglandins 1988, 35:917-938.
109. De Nucci G. Eicosanoids and skin. Biochem. Soc. Trans. 1988, 16:680-682.
110. Burke J.R. Targeting phospholipase A2 for the treatment of inflammatory skin diseases. Curr. Opin. Invest. Drugs 2001, 2:1549-1552.
111. Oyoshi M.K., He R., Kumar L., Yoon J., Geha R.S. Cellular and molecular mechanisms in atopic dermatitis. Adv. Immunol. 2009, 102:135-226.
112. Boguniewicz M., Leung D.Y. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol. Rev. 2011, 242:233-246.
113. Albanesi C. Keratinocytes in allergic skin diseases. Curr. Opin. Allergy Clin Immunol. 2010, 10:452-456.
114. Schafer L., Kragballe K. Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis. J. Invest. Dermatol. 1991, 96:10-15.
115. Honda T., Tokura Y., Miyachi Y., Kabashima K. Prostanoid receptors as possible targets for anti-allergic drugs: recent advances in prostanoids on allergy and immunology. Curr. Drug. Targets. 2010, 11:1605-1613.
116. Andoh T., Haza S., Saito A., Kuraishi Y. Involvement of leukotriene B4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions. Exp. Dermatol. 2011, 20:894-898.
117. Matsushima Y., Satoh T., Yamamoto Y., Nakamura M., Yokozeki H. Distinct roles of prostaglandin D2 receptors in chronic skin inflammation. Mol. Immunol. 2011, 49:304-310.
118. Gueck T., Seidel A., Baumann D., Meister A., Fuhrmann H. Alterations of mast cell mediator production and release by gamma-linolenic and docosahexaenoic acid. Vet. Dermatol. 2004, 15:309-314.
119. Millard T.P., Hawk J.L. Photosensitivity disorders: cause, effect and management. Am. J. Clin. Dermatol. 2002, 3:239-246.
120. Narayanan D.L., Saladi R.N., Fox J.L. Ultraviolet radiation and skin cancer. Int. J. Dermatol. 2010, 49:978-986.
121. Rijken F., Bruijnzeel-Koomen C.A. Photoaged skin: the role of neutrophils, preventive measures, and potential pharmacological targets. Clin. Pharmacol. Ther. 2011, 89:120-124.
122. Hruza L.L., Pentland A.P. Mechanisms of UV-induced inflammation. J. Invest. Dermatol. 1993, 100:35S-41S.
123. Gresham A., Masferrer J., Chen X., Leal-Khouri S., Pentland A.P. Increased synthesis of high-molecular-weight cPLA2 mediates early UV-induced PGE2 in human skin. Am. J. Physiol. 1996, 270:C1037-1050.
124. Carsberg C.J., Ohanian J., Friedmann P.S. Ultraviolet radiation stimulates a biphasic pattern of 1,2-diacylglycerol formation in cultured human melanocytes and keratinocytes by activation of phospholipases C and D. Biochem. J. 1995, 305(Pt. 2):471-477.
125. Kolgen W., Both H., van Weelden H., Guikers K.L., Bruijnzeel-Koomen C.A., Knol E.F., van Vloten W.A., De Gruijl F.R. Epidermal langerhans cell depletion after artificial ultraviolet B irradiation of human skin in vivo: apoptosis versus migration. J. Invest. Dermatol. 2002, 118:812-817.
126. Judson B.L., Miyaki A., Kekatpure V.D., Du B., Gilleaudeau P., Sullivan-Whalen M., Mohebati A., Nair S., Boyle J.O., Granstein R.D., Subbaramaiah K., Krueger J.G., Dannenberg A.J. UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression. Cancer Prev. Res. (Philadelphia) 2010, 3:1104-1111.
127. Gonzalez M.C., Marteau C., Franchi J., Migliore-Samour D. Cytochrome P450 4A11 expression in human keratinocytes: effects of ultraviolet irradiation. Br. J. Dermatol. 2001, 145:749-757.
128. Levy B.D., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2001, 2:612-619.
129. Calder P.C., Albers R., Antoine J.M., Blum S., Bourdet-Sicard R., Ferns G.A., Folkerts G., Friedmann P.S., Frost G.S., Guarner F., Lovik M., Macfarlane S., Meyer P.D., M'Rabet L., Serafini M., van Eden W., van Loo J., Vas Dias W., Vidry S., Winklhofer-Roob B.M., Zhao J. Inflammatory disease processes and interactions with nutrition. Br. J. Nutr. 2009, 101(Suppl. 1):S1-45.
130. Calder P.C. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75:197-202.
131. Chene G., Dubourdeau M., Balard P., Escoubet-Lozach L., Orfila C., Berry A., Bernad J., Aries M.F., Charveron M., Pipy B. n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARgamma activation in human keratinocyte HaCaT cells. Biochim. Biophys. Acta 2007, 1771:576-589.
132. Rhodes L.E., Durham B.H., Fraser W.D., Friedmann P.S. Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J. Invest. Dermatol. 1995, 105:532-535.
133. Lu Y., Tian H., Hong S. Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing. J. Lipid Res. 2010, 51:923-932.
134. McDaniel J.C., Massey K., Nicolaou A. Fish oil supplementation alters levels of lipid mediators of inflammation in microenvironment of acute human wounds. Wound Repair Regen. 2011, 19:189-200.
135. Martin P., Leibovich S.J. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005, 15:599-607.
136. Nichols J.A., Katiyar S.K. Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Arch Dermatol Res 2010, 302:71-83.
137. Crespy V., Williamson G. A review of the health effects of green tea catechins in in vivo animal models. J. Nutr. 2004, 134:3431S-3440S.
138. Singh T., Katiyar S.K. Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition. PLoS One 2011, 6:e25224.
139. Agarwal R., Katiyar S.K., Khan S.G., Mukhtar H. Protection against ultraviolet B radiation-induced effects in the skin of SKH-1 hairless mice by a polyphenolic fraction isolated from green tea. Photochem. Photobiol. 1993, 58:695-700.